Binds to Flashcards
(27 cards)
1
Q
LFA-3 (CD2)
A
Alefacept
2
Q
IL-2 (CD25)
A
Basiliximab
Daclizumab
3
Q
IL-1beta
A
Canakinumab
4
Q
Alpha-4 unit of integrins
A
Natalizumab
5
Q
IgE
A
Omalizumab
6
Q
IL-6
A
Tocilizumab
7
Q
IL-12, IL-23
A
Ustekinumab
8
Q
GPII/IIIa
A
Abciximab
9
Q
RANKL
A
Denosumab
10
Q
C5 complement
A
Eculizumab
11
Q
RSV Virus
A
Palivizumab
12
Q
IL-1
A
Anakinra
13
Q
CD20
A
Rituximab
Ofatumumab
Ibritumomab
Toitumomab
14
Q
CTLA4, CD28 to CD80/CD86 (so blocks T-Cell activation)
A
Abatacept
Belatacept
Ipilimumab
15
Q
JAK1, JAK3
A
Tofacitinib
16
Q
JAK1, JAK2
A
Ruxolitinib
17
Q
CD52
A
Alemtuzumab
18
Q
CD3
A
Muromonab
Catumaxomab
19
Q
NF Kappa Beta
A
Sulfasalazine
Denosumab
20
Q
TNF alpha and beta
A
Etanercept
21
Q
B Cells
A
Ofatumumab (all B cells)
Rituximab (normal and malignant)
Belimumab
22
Q
T Cells
A
Antithymocyte Globulin (ATG) and ALG Abatacept Denosumab Hydroxychloroquine Muromonab Alefacept
23
Q
B and T Cells
A
Mycophenolic Acid (MPA)
MTX
Alemtuzumab
24
Q
Targets B-Cell Stimulator (BLyS)
A
Belimumab
25
TNF alpha
```
Etanercept
Adalimumab
Infliximab
Certrolizumab pegol
Golimumab
```
26
FKBP12
Tacrolimus
| Sirolimus
27
mTOR
Sirolimus
